Next Article in Journal
SARS-CoV-2 Vaccination: What Can We Expect Now?
Next Article in Special Issue
Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
Previous Article in Journal
Durability of Antibody Response after Primary Pneumococcal Double-Dose Prime-Boost Vaccination in Adult Kidney Transplant Recipients and Candidates: 18-Month Follow-Up in a Non-Blinded, Randomised Clinical Trial
 
 
Article

Article Versions Notes

Vaccines 2022, 10(7), 1092; https://doi.org/10.3390/vaccines10071092
Action Date Notes Link
article xml file uploaded 8 July 2022 03:21 CEST Original file -
article xml uploaded. 8 July 2022 03:21 CEST Update -
article pdf uploaded. 8 July 2022 03:21 CEST Version of Record https://www.mdpi.com/2076-393X/10/7/1092/pdf-vor
article supplementary file uploaded. 8 July 2022 03:21 CEST - https://www.mdpi.com/2076-393X/10/7/1092#supplementary
article html file updated 8 July 2022 03:23 CEST Original file -
article xml file uploaded 25 July 2022 12:36 CEST Update -
article xml uploaded. 25 July 2022 12:36 CEST Update https://www.mdpi.com/2076-393X/10/7/1092/xml
article pdf uploaded. 25 July 2022 12:36 CEST Updated version of record https://www.mdpi.com/2076-393X/10/7/1092/pdf
article html file updated 25 July 2022 12:38 CEST Update -
article html file updated 13 August 2022 00:45 CEST Update https://www.mdpi.com/2076-393X/10/7/1092/html
Back to TopTop